WallStreetZenWallStreetZen

NASDAQ: PBYI
Puma Biotechnology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PBYI past revenue growth

How has PBYI's revenue growth performed historically?
Company
3.34%
Industry
149.51%
Market
17.15%
PBYI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PBYI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PBYI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PBYI earnings and revenue history

Current Revenue
$235.6M
Current Earnings
$21.6M
Current Profit Margin
9.2%

PBYI Return on Equity

Current Company
58.2%
Current Industry
-63.5%
Current Market
188%
PBYI's Return on Equity (58.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PBYI announces earnings.

PBYI Return on Assets

Current Company
10.4%
Current Industry
2.9%
PBYI is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PBYI Return on Capital Employed

Current Company
27.45%
Current Industry
19.5%
PBYI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBYI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PBYI$235.64M$47.52M$21.59M-1.25%N/A
ADAP$60.28M-$102.70M-$113.87M+0.26%N/A
PYXS$0.00-$71.20M-$73.79MN/AN/A
XERS$163.91M-$23.74M-$62.26M+132.30%N/A
XBIT$0.00-$22.57M-$24.56M-100.00%N/A
View Top Biotech Stocks

PBYI earnings dates

Next earnings date
May 2, 2024

Puma Biotechnology Earnings & Revenue FAQ

What were PBYI's earnings last quarter?

On Invalid Date, Puma Biotechnology (NASDAQ: PBYI) reported Q4 2023 earnings per share (EPS) of $0.26, up 300% year over year. Total Puma Biotechnology earnings for the quarter were $12.27 million. In the same quarter last year, Puma Biotechnology's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.

What was PBYI's earnings growth in the past year?

As of Q2 2024, Puma Biotechnology's earnings has grown year over year. Puma Biotechnology's earnings in the past year totalled $21.59 million.

What is PBYI's earnings date?

Puma Biotechnology's earnings date is Invalid Date. Add PBYI to your watchlist to be reminded of PBYI's next earnings announcement.

What was PBYI's revenue last quarter?

On Invalid Date, Puma Biotechnology (NASDAQ: PBYI) reported Q4 2023 revenue of $72.18 million up 9.9% year over year. In the same quarter last year, Puma Biotechnology's revenue was $65.68 million.

What was PBYI's revenue growth in the past year?

As of Q2 2024, Puma Biotechnology's revenue has grown 3.34% year over year. This is 146.18 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Puma Biotechnology's revenue in the past year totalled $235.64 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.